S46.801D

✓ Billable

Unspecified injury of other muscles, fascia and tendons at shoulder and upper arm level, right arm, subsequent encounter

Injury, poisoning and certain other consequences of external causes (S00-T88)

Check This Code

⚠️ Excludes2

inherited

Rules inherited from parent codes.

  • injury of muscle, fascia and tendon at elbow (S56.-)
  • sprain of joints and ligaments of shoulder girdle (S43.9)

Clinical Description

ICD-10-CM code S46.801D represents unspecified injury of other muscles, fascia and tendons at shoulder and upper arm level, right arm, subsequent encounter. This code falls under the Injury, poisoning and certain other consequences of external causes (S00-T88) classification. It is a billable/specific code valid for HIPAA-covered transactions as of October 1, 2025 (FY2026). This code can be used to indicate a diagnosis for reimbursement purposes on insurance claims.

This is a 8-character code at the 7th level of specificity. This is the most specific code available in this subcategory.

Frequently Asked Questions

What is ICD-10 code S46.801D?

ICD-10-CM code S46.801D is "Unspecified injury of other muscles, fascia and tendons at shoulder and upper arm level, right arm, subsequent encounter". It belongs to the category: Injury, poisoning and certain other consequences of external causes (S00-T88).

Is S46.801D a billable ICD-10 code?

Yes, S46.801D is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Can S46.801D be coded with other codes?

S46.801D has 2 Excludes2 note(s). These conditions can be coded together if both are documented in the patient record.

🧪 Validate Combinations

Add S46.801D to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeS46.801D
BillableYes
ParentS46.801
CategoryInjury, poisoning and certain other consequences of external causes (S00-T88)
Excludes10 rule(s)
Excludes22 note(s)

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)